Xoft

Xoft, Inc. is a medical technology company that specializes in advanced radiation therapy solutions for cancer treatment. As a subsidiary of iCAD, Inc., Xoft focuses on innovative technologies for cancer detection and radiation therapy. The company develops the Xoft® Electronic Brachytherapy System® (eBx®), an FDA-cleared and CE-marked system that uses a miniaturized x-ray source to deliver targeted radiation directly to cancerous tissues. This system is designed for use in various clinical settings, including outpatient rooms and operating theaters, without the need for a shielded room. Xoft's technology is suitable for treating early-stage breast cancer, gynecological cancers, non-melanoma skin cancer, and brain tumors. Xoft also offers a range of products, including balloon applicators, control units, and optional accessories for enhanced treatment delivery and quality assurance. The system allows for intraoperative radiation therapy (IORT) and accelerated partial breast irradiation (APBI), improving workflow and patient care by enabling medical personnel to remain in the room during treatment.

• Employees 50
• Founded 1998
• Annual Revenue $13000000
• Total Funding $70300663